Vivo Capital’s 89bio ETNB Stock Holding History

Vivo Capital’s Portfolio ETNB Stock Details ETNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-376,804	Closed	-$5.54M	–	51
2025 Q3	$5.54M	Hold	376,804	–	–	0.45%	41
2025 Q2	$3.7M	Hold	376,804	–	–	0.38%	37
2025 Q1	$2.74M	Buy	+376,804	New	+$3.29M	0.36%	35
2020 Q4	–	Sell	-183,042	Closed	-$4.7M	–	63
2020 Q3	$4.7M	Buy	+183,042	New	+$5.81M	0.27%	52

Other funds holding ETNB

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vivo Capital's ETNB Position: Q4 2025 in Review

Vivo Capital sold out of 89bio (ETNB) in Q4 2025, closing a stake of 376,804 shares — an estimated $5.54M sold.

Vivo Capital first reported a position in ETNB in Q3 2020 and held it in 4 quarters. The position peaked at $5.54M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

Vivo Capital reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
Vivo Capital sold 376,804 89bio shares in Q4 2025, an estimated $5.54M.
Vivo Capital first reported a position in 89bio in Q3 2020 and held it in 4 quarters.
Vivo Capital's 89bio position peaked at $5.54M in Q3 2025.
2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Vivo Capital's 13F filing for Q4 2025, filed 13 Feb 2026.